Search research articles
Contact Us
Filters
Showing results (31-40 of 207) with videos related to
Page
of 21
Sort By:
Clinical Advances in Hematology & Oncology : H&O
|
August 17, 2012
Systemic therapy of advanced pancreatic cancer: has the landscape changed?
Minsig Choi, Saqib Razzaque, Richard Kim
JOP : Journal of the Pancreas
|
March 13, 2012
BRCA and pancreatic cancer: selection of chemotherapy
Richard Kim, Jenifer Byer, Muhammad Wasif Saif
JOP : Journal of the Pancreas
|
March 12, 2013
First-line treatment for advanced pancreatic cancer
Nishi Kothari, Muhammad Wasif Saif, Richard Kim
JOP : Journal of the Pancreas
|
March 13, 2014
Is there a role for second line therapy in advanced pancreatic cancer?
Minsig Choi, Muhammad Wasif Saif, Richard Kim
Immunotherapy
|
July 13, 2025
Predictive biomarkers for immune checkpoint inhibition for patients with colorectal cancer: a comprehensive review
Ibrahim Halil Sahin, Turcin Saridogan, Richard Kim
JOP : Journal of the Pancreas
|
July 9, 2011
Adjuvant treatment for ampullary cancer. Highlights from the "2011 ASCO Annual Meeting". Chicago, IL, USA; June 3-7, 2011
Richard Kim, John Chabot, Muhammad Wasif Saif
JOP : Journal of the Pancreas
|
March 13, 2012
What options are available for refractory pancreatic cancer?
Minsig Choi, Richard Kim, Muhammad Wasif Saif
Journal of Gastrointestinal Oncology
|
May 9, 2017
Hepatocellular carcinoma (HCC): beyond sorafenib-chemotherapy
Dae Won Kim, Chetasi Talati, Richard Kim
Expert Opinion on Investigational Drugs
|
December 30, 2020
Regorafenib, an investigational agent for the treatment of cholangiocarcinoma
Ibrahim Halil Sahin, Elaine Tan, Richard Kim
Expert Opinion on Investigational Drugs
|
November 13, 2015
Investigational drugs for treating anal cancer and future perspectives
Liliana Bustamante, Jessica Frakes, Sarah Hoffe, et al.
Page
of 21
Search research articles
Search
Showing results (31-40 of 207) with videos related to
Sort By:
Page
of 21
Clinical Advances in Hematology & Oncology : H&O
|
August 17, 2012
Systemic therapy of advanced pancreatic cancer: has the landscape changed?
Minsig Choi, Saqib Razzaque, Richard Kim
JOP : Journal of the Pancreas
|
March 13, 2012
BRCA and pancreatic cancer: selection of chemotherapy
Richard Kim, Jenifer Byer, Muhammad Wasif Saif
JOP : Journal of the Pancreas
|
March 12, 2013
First-line treatment for advanced pancreatic cancer
Nishi Kothari, Muhammad Wasif Saif, Richard Kim
JOP : Journal of the Pancreas
|
March 13, 2014
Is there a role for second line therapy in advanced pancreatic cancer?
Minsig Choi, Muhammad Wasif Saif, Richard Kim
Immunotherapy
|
July 13, 2025
Predictive biomarkers for immune checkpoint inhibition for patients with colorectal cancer: a comprehensive review
Ibrahim Halil Sahin, Turcin Saridogan, Richard Kim
JOP : Journal of the Pancreas
|
July 9, 2011
Adjuvant treatment for ampullary cancer. Highlights from the "2011 ASCO Annual Meeting". Chicago, IL, USA; June 3-7, 2011
Richard Kim, John Chabot, Muhammad Wasif Saif
JOP : Journal of the Pancreas
|
March 13, 2012
What options are available for refractory pancreatic cancer?
Minsig Choi, Richard Kim, Muhammad Wasif Saif
Journal of Gastrointestinal Oncology
|
May 9, 2017
Hepatocellular carcinoma (HCC): beyond sorafenib-chemotherapy
Dae Won Kim, Chetasi Talati, Richard Kim
Expert Opinion on Investigational Drugs
|
December 30, 2020
Regorafenib, an investigational agent for the treatment of cholangiocarcinoma
Ibrahim Halil Sahin, Elaine Tan, Richard Kim
Expert Opinion on Investigational Drugs
|
November 13, 2015
Investigational drugs for treating anal cancer and future perspectives
Liliana Bustamante, Jessica Frakes, Sarah Hoffe, et al.
Page
of 21